NeoImmuneTech’s drug NT-I7 has shown the potential to reduce the number of cells needed in a CAR-T therapy infusion fivefold, as well as boosting survival rates.
[Fierce Biotech]
Home Newsletters Human Immunology News CAR-T Countdown: NeoImmuneTech Drug Could Reduce Number of Cells Needed for Cancer...
